Geneoscopy CEO Andrew Barnell On Transforming GI Health: RNA-Based Diagnostics, CRC Screening Opportunity, & Platform Potential Ahead

Recorded on 07/09/26 TD Cowen Life Science & Diagnostic Tools analyst Dan Brennan speaks with Geneoscopy CEO Andrew Barnell post TD Cowen's 5th Annual Tools/Dx Revolution Conference to discuss GI healthcare and the future of GI cancer diagnostics, and Geneoscopy's innovations, partnerships, and growth pillars ahead. Geneoscopy is leveraging its proprietary RNA platform to advance colorectal cancer…